Literature DB >> 7753836

G1 phase arrest induced by Wilms tumor protein WT1 is abrogated by cyclin/CDK complexes.

T Kudoh1, T Ishidate, M Moriyama, K Toyoshima, T Akiyama.   

Abstract

WT1, the Wilms tumor-suppressor gene, maps to the human chromosomal region 11p13 and encodes a transcriptional repressor, WT1, implicated in controlling normal urogenital development. Microinjection of the WT1 cDNA into quiescent cells or cells in early to mid G1 phase blocked serum-induced cell cycle progression into S phase. The activity of WT1 varied significantly depending on the presence or absence of an alternatively spliced region located upstream of the zinc finger domain. The inhibitory activity of WT1 was abrogated by the overexpression of cyclin E/CDK2 as well as cyclin D1/CDK4. Furthermore, both CDK4- and CDK2-associated kinase activities were downregulated in cells overexpressing WT1, whereas the levels of CDK4, CDK2, and cyclin D1 expression were unchanged. These findings suggest that inhibition of the activity of cyclin/CDK complexes may be involved in mediating the WT1-induced cell cycle block.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7753836      PMCID: PMC41975          DOI: 10.1073/pnas.92.10.4517

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

2.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

Authors:  A Noda; Y Ning; S F Venable; O M Pereira-Smith; J R Smith
Journal:  Exp Cell Res       Date:  1994-03       Impact factor: 3.905

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

4.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

5.  Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

Authors:  K Polyak; M H Lee; H Erdjument-Bromage; A Koff; J M Roberts; P Tempst; J Massagué
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

6.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

7.  WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant.

Authors:  D A Haber; S Park; S Maheswaran; C Englert; G G Re; D J Hazen-Martin; D A Sens; A J Garvin
Journal:  Science       Date:  1993-12-24       Impact factor: 47.728

8.  A cyclin associated with the CDK-activating kinase MO15.

Authors:  T P Mäkelä; J P Tassan; E A Nigg; S Frutiger; G J Hughes; R A Weinberg
Journal:  Nature       Date:  1994-09-15       Impact factor: 49.962

9.  D-type cyclin-dependent kinase activity in mammalian cells.

Authors:  H Matsushime; D E Quelle; S A Shurtleff; M Shibuya; C J Sherr; J Y Kato
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  A novel cyclin associates with MO15/CDK7 to form the CDK-activating kinase.

Authors:  R P Fisher; D O Morgan
Journal:  Cell       Date:  1994-08-26       Impact factor: 41.582

View more
  11 in total

1.  Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

Authors:  S Maheswaran; C Englert; G Zheng; S B Lee; J Wong; D P Harkin; J Bean; R Ezzell; A J Garvin; R T McCluskey; J A DeCaprio; D A Haber
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

2.  The Wilms tumor protein is persistently associated with the nuclear matrix throughout the cell cycle.

Authors:  Y Dobashi; T Kudoh; T Ishidate; M Shoji; K Toyoshima; T Akiyama
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

3.  A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1.

Authors:  R W Johnstone; R H See; S F Sells; J Wang; S Muthukkumar; C Englert; D A Haber; J D Licht; S P Sugrue; T Roberts; V M Rangnekar; Y Shi
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

4.  Tumor suppressor p53 can participate in transcriptional induction of the GADD45 promoter in the absence of direct DNA binding.

Authors:  Q Zhan; I T Chen; M J Antinore; A J Fornace
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Expression and function of the leucine zipper protein Par-4 in apoptosis.

Authors:  S F Sells; S S Han; S Muthukkumar; N Maddiwar; R Johnstone; E Boghaert; D Gillis; G Liu; P Nair; S Monnig; P Collini; M P Mattson; V P Sukhatme; S G Zimmer; D P Wood; J W McRoberts; Y Shi; V M Rangnekar
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

Review 6.  Asbestos and mesothelioma: genetic lessons from a tragedy.

Authors:  A Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.

Authors:  L W Ellisen; N Carlesso; T Cheng; D T Scadden; D A Haber
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

Review 8.  Wilms tumor gene (WT1) expression as a panleukemic marker.

Authors:  Hans D Menssen; Jan M Siehl; Eckhard Thiel
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

9.  Cell cycle regulation and differentiation in the human podocyte lineage.

Authors:  M Nagata; K Nakayama; Y Terada; S Hoshi; T Watanabe
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Expression of inhibin-alpha is regulated synergistically by Wilms' tumor gene 1 (Wt1) and steroidogenic factor-1 (Sf1) in sertoli cells.

Authors:  Shao-Yang Ji; Jian-Xiu Hao; Lei Li; Jun Zhang; Qiao-Song Zheng; Xi-Xia Li; Xiao-Na Wang; Chun-Sheng Han; Fei Gao; Yi-Xun Liu
Journal:  PLoS One       Date:  2013-01-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.